Stig Rödjer

Basic information

name:
Stig Rödjer
profession:
Docent, överläkare
email:

Work

department:
Sektionen för Hematologi och Koagulation
workplace:
Sahlgrenska Universitetssjukhuset
phone number:
city:
SE-413 45 Göteborg
country:
Sverige

Article - Review (1)

  1. [Peripherally inserted central venous catheter still not evaluated for clinical use. More scientific support is needed according to a literature study].
    [Perifert inlagd central venkateter ännu inte utvärderad för kliniskt bruk. Mer vetenskapligt stöd krävs, visar litteraturstudie.]
    Hammarskjöld F, Nielsen N, Rödjer S, Pärsson H, Falkmer U, Malmvall BE.
    Lakartidningen 2008:105(21):1576-80.

Article - Peer reviewed scientific (19)

  1. Hoppe M, Lönnerdal B, Hossain B, Olsson S, Nilsson F, Lundberg PA, Rödjer S, Hulthén L.
    J Nutr Biochem. 2009:20(1):11-6.
    Web of Science® citations 18
  2. Hoppe M, Lönnerdal B, Bakhtiar H, Olsson S, Nilsson F, Lundberg P, Rödjer S, Hulthén L.
    Journal of Nutritional Biochemistry 2009:20(1):11-16.
    Web of Science® citations 18
  3. Rodriguez-Catarino M, Blimark C, Willén J, Mellqvist UH, Rödjer S.
    Eur Spine J 2007:16 Suppl 3:242-9.
    Web of Science® citations 25
  4. Olsson-Strömberg U, Höglund M, Björkholm M, Braide I, Carlson K, Gahrton G, Grimfors G, Hast R, Lerner R, Linder O, Ljungman P, Löfvenberg E, Malm C, Nilsson PG, Paul C, Rödjer S, Stenke L, Tidefeldt U, Turesson I, Uden AM, Wahlin A, Vilen L, Winqvist I, Zettervall O, Oberg G, Simonsson B.
    Leuk Lymphoma 2006:47(9):1768-73.
    Web of Science® citations 2
  5. [Early professional contact supports professional development of medical students. EPC--a new course in medical education in Gothenburg].
    [Tidig yrkeskontakt stärker studenternas professionella utveckling. TYK--en ny kurs i läkarutbildningen i Göteborg.]
    Hellquist G, Rödjer S, von Below B, Sveinsdóttir G, Björkelund C.
    Lakartidningen 2005:102(38):2646-8, 2650-1.
  6. Olsson-Strömberg U, Simonsson B, Ahlgren T, Björkholm M, Carlsson K, Gahrton G, Hast R, Löfvenberg E, Linder O, Ljungman P, Malm C, Paul C, Rödjer S, Turesson I, Udén AM, Wahlin A, Killander A, Wadman B, Westin J, Vikrot O, Zettervall O, Oberg G;
    Swedish CML Study Group.
    Hematol J. 2004:5(6):462-6.
    Web of Science® citations 4
  7. Westin J, Rödjer S, Jagenburg R, Jernås M.
    Läkartidningen 1987:84(8):555-7.
  8. Rödjer S, Westin J, Jagenburg R, Jarnas M.
    Läkartidningen 1987:84
  9. Trollfors B, Alestig K, Rödjer S, Sandberg T, Westin J.
    Journal Antimicrob Chemother 1983:12:641-5.

Book Chapter (1)

  1. Wahlqvist M, Rödjer S, Rödjer S.
    För framtidens hälsa - en ny läkarutbildning Statens offentliga utredningar. Fritzes förlag; 2013, pp 289-303. ISBN 978-91-38-23900-1.

Conference Poster (1)

  1. Rödjer S, von Below B, Karlsson M, Leander K, Wahlqvist M.
    AMEE Conference Programme Prague 2008; 2008.

Article - Other scientific (1)

  1. Läkartidningen 2012:109(29-31):1328-29.

Scientific publications

1.Jagenburg R, Nagy A, Rödjer S. Separation of p-acetamidophenol metabolites by gel filtration on Sephadex G 10. Scand J Clin Lab Invest 1968;22:11-6.
2.Jagenburg R, Rödjer S, Samsioe G. Separation of urinary constituents of low molecular weight on Sephadex G 10. Scand J Clin Lab Invest 1968;22:54-6.
3.Hjalmarsson O, Jagenburg R, Rödjer S. Mild and severe PKU. Comparative studies in two infants. Acta Paediatr Scand 1971;60:11-6.
4.Granerus AK, Jagenburg R, Rödjer S, Svanborg A. Inhibition of L-Phenylalanine absorption by L-DOPA in patients with parkinsonism. Proc Soc Exp Biol Med 1971;137:942-4.
5.Granerus AK, Jagenburg R, Rödjer S, Svanborg A. Phenylalanine absorption and metabolism in Parkinsonian patients. Br Med J 1971;4:262-4.
6.Jagenburg R, Lindblad B, De Mare JM, Rödjer S. Hereditary tyrosinemia: metabolic studies in a patient with partial p-hydroxyphenylpyruvate hydroxylase activity. J Pediatr 1972;80:994-1004.
7.Knutsson F, Lindstedt G, Norrby A, Rödjer S. Fall av klorokininducerad porfyrinuri. Läkartidningen 1973;70:1547-8.
8.Hjalmarsson O, Jagenburg R, Rödjer S. In vivo-studier av fenylalaninomsättningen. Läkartidningen 1974;71:1171-2.
9.Granerus AK, Jagenburg R, Rödjer S, Svanborg A. Variations in L-dopa absorption. Report of a parkinsonian patient with high plasma dopa concentration after therapeutical L-dopa dose. Acta Med Scand 1974;196:459-63.
10.Jagenburg R, Rödjer S. Detection of heterozygotes for phenylketonuria by constant intravenous infusion of L-phenylalanine. Clin Chem 1977;23:1661-5.
11.Jagenburg R, Regårdh CG, Rödjer S. Detection of heterozygotes for phenylketonuria. Total body phenylalanine clearance and concentrations of phenylalanine and tyrosine in the plasms of fasting subjects compared. Clin Chem 1977;23:1654-60.
12.Jagenburg R, Olsson R, Regårdh CG, Rödjer S. Kinetics of intravenous administered L-phenylalanine in patients with cirrhosis of the liver. Clin Chim Acta 1977;78:453-63.
13.Magnusson B, Rödjer S. Alprenolol-induced thrombocytopenia. Acta Med Scand 1980;207:231-3.
14.Granerus A-K, Hallhagen U, Holm G, Leissner U, Rödjer S, Westin J. (Göteborgsmodellen I) Bättre samarbete akutvård-långvård. Läkartidningen 1981;78: 915-18.
15.Leissner U, Rödjer S, Westin J. (Göteborgsmodellen II) Styrd ”överföring” till eftervård, konvalescentvård och sjukhemsvård. Erfararenheter av centralt remitteringssekretariat i Göteborg 1975-1978. Läkartidningen 1981;78:1156-58.
16.Rödjer S. Orsaker till medvetanderubbning hos alkoholmissbrukare. Läkartidningen 1981;78:3382-4.
17.Magnusson B, Rödjer S, Wiholm BE. Hematologiska biverkningar av antihypertensiva läkemedel. Läkartidningen 1981;78:1761-3.
18.Magnusson B, Rödjer S. Öppenvårdsenhet för hematologi-kvalificerad sjukvård till låg kostnad. Läkartidningen 1982;79:1496-8.
19.Jagenburg R, Regårdh CG, Rödjer S. Influence or age and sex on the kinetics of intravenously administered L-phenylalanine. Clin Chem 1982;28:204-6.
20.Trollfors B, Alestig K, Rödjer S, Sandberg T, Westin J. Renal function in patients treated with tobramycin-cefuroxime or tobramycin-penicillin G. J Antimicrob Chemother 1983;12:641-5.
21.Rödjer S, Swolin B, Westin J. Monoclonal gammopathy--a diagnostic challenge. Illustrated by four cases of multiple myeloma with an unusually indolent (smoldering) course. Acta Med Scand 1983;214:325-9.
22.Brorson JE, Falsen E, Nilsson-Ehle H, Rödjer S, Westin J. Septicemia due to Moraxella nonliquefaciens in a patient with multiple myeloma. Scand J Infect Dis 1983;15:221-3.
23.Bäck H, Gustavsson B, Rödjer S, Westin J. Primart gastrointestinalt lymfom--en differentialdiagnos vid akut buk. Läkartidningen 1983;80:2839-40.
24.Ridell B, Olafsson JH, Roupe G, Swolin B, Granerus G, Rödjer S, Enerbäck L. The bone marrow in urticaria pigmentosa and systemic mastocytosis. Cell composition and mast cell density in relation to urinary excretion of tele-methylimidazoleacetic acid. Arch Dermatol 1986;122:422-7.
25.Westin J, Rödjer S, Jagenburg R, Järnås M. Pseudotrombocytopeni--en laboratoriesjukdom. Läkartidningen 1987;84:555-7.
26.Rödjer S, Alestig K, Bergmark J, Bergström T, Hultberg B, Jagenburg R, Olaisson L, Trollfors B, Westin J. Treatment of septicaemia in immunocompromised patients with ceftazidime or with tobramycin and cefuroxime, with special reference to renal effects. J Antimicrob Chemother 1987;20:109-16.
27.Swolin B, Rödjer S, Roupe G. Cytogenetic studies and in vitro colony growth in patients with mastocytosis. Blood 1987;70:1928-32.
28.Bäck H, Gustavsson B, Ridell B, Rödjer S, Westin J. Primary gastrointestinal lymphoma incidence, clinical presentation, and surgical approach. J Surg Oncol 1986;33:234-8.
29.AlObaidy A, Rödjer S, Alestig K, Carlberg H, Suurkula M. Hudbiopsi vid svampsepsis--en genväg till diagnos. Läkartidningen 1987;84:4147-8.
30.Lindblad R, Kaijser B, Magnusson B, Rödjer S, Westin J. Pneumococcal vaccination in splenectomized patients with hematological disorders. Acta Med Scand 1988;224:467-71.
31.v Bültzingslöwen I, Cars O, Heimdahl A, Nord CE, Rådegran K, Rödjer S. Antibiotikaprofylax for riskpatienter i odontologisk praxis. Tandläkartidningen 1988;80:1424-30.
32.Lindblad R, AlObaidy A, Mobacken H, Rödjer S. Diagnostically usable skin lesions in Candida septicaemia. Mycoses 1989;32:416-20.
33.Swolin B, Rödjer S, Westin J. Bone marrow in vitro growth and cytogenetic studies in patients with FAB-classified primary myelodysplastic syndromes. Am J Hematol 1990;34:175-80.
34.Rödjer S, Vikrot O, Wahlin A, Westin J. Effect of interferon alpha-2b in advanced multiple myeloma. J Intern Med 1990;227:45-8.
35.Rödjer S, Swolin B, Weinfeld A, Westin J. Cytogenetic abnormalities in acute leukemia complicating melphalan-treated multiple myeloma. Cancer Genet Cytogenet 1990;48:67-73.
36.Nilsson-Ehle H, Bremell T, Mobacken H, Norrsell K, Rödjer S. Längs Sidenvägen och i Sverige: Morbus Behcet--sällsynt systemsjukdom som drabbar främst yngre personer. Läkartidningen 1990;87:3311-4.
37.Hjorth M, Hellquist L, Holmberg E, Magnusson B, Rödjer S, Westin J. Initial treatment in multiple myeloma: no advantage of multidrug chemotherapy over melphalan-prednisone. The Myeloma Group of Western Sweden. Br J Haematol 1990;74:185-91.
38.Bäck H, Lindblad R, Rödjer S, Westin J. Single-dose intravenous melphalan in advanced multiple myeloma. Acta Haematol 1990;83:183-6.
39.Westin J, Cortelezzi A, Hjorth M, Rödjer S, Turesson I, Zador G. Interferon therapy during the plateau phase of multiple myeloma: an update of the Swedish study. Eur J Cancer 1991;27 Suppl 4:S45-8.
40.Lindblad R, Rödjer S. A case of severe pancytopenia caused by ibuprofen. J Intern Med 1991;229:281-3.
41.Bäck H, Nilsson G, Hansson GK, Rödjer S, Tarkowski A. M-component with reactivity against actin associated with thrombotic thrombocytopenic purpura. Am J Med 1991;91:429-33.
42.Hjorth M, Holmberg E, Rödjer S, Westin J. Impact of active and passive exclusions on the results of a clinical trial in multiple myeloma. The Myeloma Group of Western Sweden. Br J Haematol 1992;80:55-61.
43.Swolin B, Kristiansen IH, Rödjer S, Hellström-Lindberg E. Variable growth in vitro of chromosomally different stem cells in myelodysplastic syndromes. Leuk Res 1993;17:927-32.
44.Hjorth M, Hellquist L, Holmberg E, Magnusson B, Rödjer S, Westin J. Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I--a randomized study. Myeloma Group of Western Sweden. Eur J Haematol 1993;50:95-102.
45.Bäck H, Jagenburg R, Rödjer S, Westin J. Serum deoxythymidine kinase: no help in the diagnosis and prognosis of monoclonal gammopathy. Br J Haematol 1993;84:746-8.
46.Swolin B, Rödjer S, AlObaidy A, Jonell R, Roupe G. A follow-up study of bone marrow chromosomes and in vitro colony growth in patients with mastocytosis. Acta Derm Venereol (Stockh) 1994;74:163-7.
47.Westin J, Rödjer S, Turesson I, Cortelezzi A, Hjorth M, Zador G. Interferon alfa-2b versus no maintenance therapy during the plateau phase in multiple myeloma: a randomized study. Cooperative Study Group. Br J Haematol 1995;89:561-8.
48.Hjorth M, Holmberg E, Rödjer S, Taube A, Westin J. Patient accrual and quality of participation in a multicentre study on myeloma: a comparison between major and minor participating centres. Br J Haematol 1995;91:109-15.
49.Bäck H, Gustavsson A, Eksborg S, Rödjer S. Accidental doxorubicin overdosage. Acta Oncol 1995;34:533-6.
50. The Nordic Myeloma Study Group. Interferon-alfa2b added to melphalan-prenisone for initial and maintenance therapy in multiple myeloma. A randomized, controlled trial. Ann Intern Med 1996;124:212-22.
51.Hjorth M, Holmberg E, Rödjer S, Taube A, Westin J. Physicians' attitudes toward clinical trials and their relationship to patient accrual in a Nordic multicenter study on myeloma. Control Clin Trials 1996;17:372-86.
52.Lindblad R, Rödjer S, Adriansson M, Andreasson B, Bäckström B, Johansson P, Karlsson K, Rhedin C, Turesson I. Empiric monotherapy for febrile neutropenia--a randomized study comparing meropenem with ceftazidime. Scand J Infect Dis 1998;30:237-43.
53.Hjorth M, Holmberg E, Rödjer S, Turesson I, Westin J, Wislöff F. Survival in conventionally treated younger (<60 years) multiple myeloma patients: no improvement during two decades. Nordic Myeloma Study Group (NMSG). Eur J Haematol 1999;62:271-7.
54.Swolin B, Rödjer S, Roupe G. Cytogenetic studies in patients with mastocytosis. Cancer Genet Cytogenet 2000;120:131-5.
55.Lenhoff S, Hjorth M, Holmberg E, Turesson I, Westin J, Nielsen JL, Wislöff F, Brinch L, Carlson K, Carlsson M, Dahl IM, Gimsing P, Hippe E, Johnsen H, Lamvik J, Löfvenberg E, Nesthus I, Rödjer S. Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group. Blood 2000;95:7-11.
56.Rödjer S, Nilsson B, Westin J. Do anthracyclines have a role in the therapy of multiple myeloma? Hematol J 2000;1:422-6.
57.Dammacco F, Castoldi G, Rödjer S. A placebo-controlled study on the effect of epoetin alfa in patients with multiple myeloma. Br J Haematol 2001;113:172-9.
58.Haglind E, Brantevik Å, Friman S, Jertborn M, Rödjer S, Seeberg S. Framgångsrikt kontrollprogram har hävt MRSA-utbrottet. Läkartidningen 2001;98:5312-3.
59.Blomberg J, Jansson S, Rödjer S, Birkhed D. Salivary secretion rate after chemotherapy in patients with malignant haematological disease. A pilot study. Swed Dent J 2002;26:75-80.
60.Swolin B, Rödjer S, Ögärd I, Roupe G. Trisomies 8 and 9 not detected with FISH in patients with mastocytosis. Am J Hematol 2002;70:324-5.
61.Andersson P, Höglund M, Rödjer S. Pulmonary side-effects of interferon-a in patients with hematological malignancies. Am J Hematol 2003;73:54-8.
62.Bram S, Swolin B, Rödjer S, Stockelberg D, Ögärd I, Bäck H. Is monosomy 5 an uncommon aberration?-FISH revealed translocations and deletions in MDS or AML. Cancer Genet Cytogen 2003;142:107-14.
63.Löfgren C, Paul C, Åström M, Hast R, Hedenius M, Lerner R, Lilienmark J, Nilsson I, Rödjer S, Simonsson B, Stockelberg D, Tidefelt U, Björkholm M. Granulocyte-macrophage colony-stimulating factor to increase efficacy of mitoxanteone, etoposide and cytarabine to previous untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomised trial. Br J Haematol 2004;124:474-80.
64.Bram S, Rödjer S, Swolin B. Several chromosomes involved in translocations with chromosome 5 showed by FISH in patients with malignant myeloid disorders. Cancer Genet Cytogen. 2004;155:74-8.
65. Olsson-Strömberg U. för svenska KML-gruppen. Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukemia. BMT prolongs survival. Hematol J 2004;5:462-6.
66. Hellquist G, Rödjer S, Sveinsdottir G, von Below B, Björkelund C. Studenternas första möten med sitt framtida yrke. Tidig yrkeskontakt (TYK)- en ny kurs i läkarutbildningen i Göteborg. Läkartidningen 2005;102;2646-51. .
67. Landahl G, Börjesson M, Adolfsson P, Mannheimer C, Rödjer S. Iron defiency and anemia-a common problem in female elite soccer players. Int J Sport Nutr Exe Metabolism. 2005; 15:689-94.
68.Rodriguez-Catarino M, Blimark C, Willén J, Mellqvist U-H, Rödjer S. Percutaneous
vertebroplasty at C2: case report of a patient with multiple myelima and a literature review. Eur Spine J 2007; 16 (suppl 3):S242-9.
69. Swolin B,Rödjer S, Westin J.Therapy-related patterns of cytogenetic abnormalities in acute myeliod leukemia and myelodysplastic syndrome post polycythemia vera, single center experience and review of literature. AAnn Hematol 2008; 87;467-74.
70.Hoppe M, Lönnerdahl B, Hossain B, Olsson S, Nilsson F, Lundberg PA, Rödjer S, Hulthén L. Heocidin, interleukin-6 and hematological iron markers in males before and after heart surgery. J Nutr Biochem 2009; 20:11-6.
71.Hammarskjöld F, Nielsen N, Rödjer S, Pärsson H, Falkmer U, Malmvall BE. Peripherally inserted central venous catheter still not evaluated för clinical use. More scientific support is needed according to a literature study.Läkartidningen 2008; 105:1576-80.
72. von Below B. Hellquist G, Rödjer S, Gunnarsson R, Björkelund C, Wahlqvist M. Medical students´and facilitators´experiences of an Early Professional Contact Course:active and motivated students, strained facilitators. BMC Med Educ 2008; dec 2:8:566
73. Blimark C, Veskovski L, Westin J, Rödjer S, Brune M, Hjorth M, Holmberg E, Andersson PO, Mellqvist UH. Melphalan 100 mg(m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remssion after autologous stem cell transplantation. Eur J Haematol 2011; 87:117-22.
von below B, Rödjer S, Wahlqvist M, Billhult A. "I couldn´t do this with opposition from my colleagues" a quanrtrave study of physicians´experiences as clinical tutors. BMC Med Educ 2011oct5.

7

Other publications

1.Rödjer S. Internmedicin en specialitet som spricker ?. G-P 940314
2.Hammeland R, Melkersson M, Rödjer S. Patientflöden vid vårdenheter för internmedicin och geriatrik under åren 1990-93. Rapport Göteborgs sjukvård 1996.
3.Rödjer S, Bäck H, Kronholm E. Hematologi i England-Intryck från en studieresa till London. Haema (Blodcancerförbundets tidskrift) nr 1 1997
4.Nilsson G, Rödjer S. Myelom och skelettet. Astra Läkemedel 1997
5.Rödjer S, Tengborn L Recension ”Blodsjukdomar. Lärobok i hematologi”. Läkartidningen 1998;95:3702-4.
6.Myeloma Trialists´ Collaborative Group. Combination chemotherapy versus melphalan plus prednisone as treatment för multiple myeloma: an overview of 6633 patients from 27 randomized trials. J Clin Oncol 1998;12:3832-42.
7.Myeloma Trialists´ Collaborative Group. Interferon as therapy for multiple myeloma: an individual overview of 24 randomised trials and 4012 patients. Br J Haematol 2001;113:1020-34.

Work experience

WorkplaceDegree of EmploymentStartedEnded
Landsting - Västra Götalandsregionen - Specialiserad vård - Sahlgrenska Universitetssjukhuset - Område 6 - Medicin, Sahlgrenska workplace verified by Västra Götalandsregionen on 2018-02-27
100% 1969 2006

2002 Göteborgs Universitets Pedagogiska lagpris tillsammans med Gunilla Hellquist och Bernhard von Below för införande av kursen "Tidig yrkeskontakt".
Information is not reliable | confirmed 2016-10-19 by Stig Rödjer | reminder 2018-03-04 | 4

User account for Stig Rödjer, from FoU i Sverige
http://www.researchweb.org/is/sverige/user/html/2497